HLN (Haleon) Total Receivables: $2,582 Mil (As of Dec. 2025)


HLN Haleon PLC HLN
70 GF Score
Price $9.75
GF Value $9.80
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Haleon Total Receivables?

Haleon HLN -0.91% 70 Total Receivables is $2,582 Mil as of Dec. 2025. GuruFocus rates HLN with a GF Score™ of 70/100 and a GF Value™ of $9.80 (Fairly Valued). The stock has 3 warning signs investors should review.

Haleon's Total Receivables for the quarter that ended in Dec. 2025 was $2,582 Mil.

Haleon Total Receivables Historical Data

* Premium members only.

The historical data trend for Haleon's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleon Total Receivables Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial 4,940.16 2,291.11 2,130.38 2,407.08 2,582.33

Haleon Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,130.38 2,717.56 2,407.08 2,909.09 2,582.33
HLN
70GF Score
Haleon PLC HLN
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haleon Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $2,582 Mil mean?
Haleon (HLN) has a Total Receivables of $2,582 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Haleon and its competitors.
Is Haleon's Total Receivables too high?
Haleon's current Total Receivables is $2,582 Mil. Overall, Haleon has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Haleon's Total Receivables compare to ZTS and UTHR?
Haleon's Total Receivables of $2,582 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Haleon and its competitors. Haleon's current Total Receivables is $2,582 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleon stock overvalued right now?
Based on GuruFocus' analysis, Haleon (HLN) is currently considered Fairly Valued. The stock's GF Value™ is $9.80, compared to a current price of $9.75 — trading 0.5% below its estimated fair value. The current Total Receivables is $2,582 Mil. Haleon's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Haleon (HLN), the current Total Receivables is $2,582 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleon (HLN) Overvalued in 2026?

Based on GuruFocus' analysis, Haleon stock appears to be undervalued. The current stock price of $9.75 is trading 0.5% below its estimated GF Value™ of $9.80. GuruFocus considers Haleon to be Fairly Valued.

Key valuation signals for HLN:

  • Total Receivables: $2,582 Mil
  • GF Value™: $9.80 vs. price of $9.75 (0.5% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the HLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haleon Business Description

Address The Heights, Building 5, First Floor, Weybridge, Surrey, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
70GF Score

Get the complete analysis for HLN

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.75
Price
$9.80
GF Value